Goodman Announces MABA’s “Best of the Best” Winners
Partner Stephen Goodman, Co-Chair of Pryor Cashman’s Life Sciences Group and co-founder of Mid Atlantic Bio Angels (MABA), was quoted in the press announcing MABA’s 2016 “Best of the Best” competition winners.
This year, NangioTx – a Houston-based drug development company developing a novel drug that promotes the growth of new blood vessels in the muscles of patients with peripheral artery disease, which causes muscle atrophy and cell death – took home the coveted honor.
“After more than two hours of pitches and despite being second to the last of the nine presenters, the audience of nearly 150 who remained through the evening expressed great enthusiasm for NangioTx’s pitch and its revascularization technology,” Goodman said.
As winner of “Best of the Best,” NangioTx will receive select services free of charge from sponsors of the event, including technology transfer and licensing counsel from Pryor Cashman.
The full press announcement can be found here.
More About 1st Pitch Life Science
Each year, MABA invites early stage life sciences and healthcare companies to present before a panel of experienced life science investors and consultants, followed by a short audience Q&A. Presenters at 1st Pitch then have the unique benefit of hearing first-hand from the panel as they offer a constructive critique of their business model and perceived viability in the market.
Pryor Cashman’s Life Sciences Practice
Our Life Sciences attorneys actively nurture entrepreneurs from the onset of their new ventures, advising on how best to structure their businesses and implement choices, acquiring rights to core technologies and connecting them with potential funding sources such as angel investors, institutional investors, and biotech and health care company venture arms.
We shepherd our clients through transactions, ensuring their critical innovations are protected, and help them secure the best minds and scientific talent to bring their technologies to the global market.
To learn more about our experience in this area, please visit our practice page.
